An Open Label Study of GBT440 to Evaluate the Effect on Oxygenation in Healthy Subjects at Rest and Maximal Exercise Under Hypoxic Conditions

Trial Profile

An Open Label Study of GBT440 to Evaluate the Effect on Oxygenation in Healthy Subjects at Rest and Maximal Exercise Under Hypoxic Conditions

Recruiting
Phase of Trial: Phase I

Latest Information Update: 06 Oct 2017

At a glance

  • Drugs GBT 440 (Primary)
  • Indications Hypoxia; Idiopathic pulmonary fibrosis; Sickle cell anaemia
  • Focus Therapeutic Use
  • Acronyms Basecamp Study
  • Sponsors Global Blood Therapeutics
  • Most Recent Events

    • 29 Sep 2017 Planned number of patients changed from 12 to 20.
    • 29 Sep 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Dec 2017.
    • 17 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top